Wide World of Stocks Secures Agreements with WNBC and ION Television Networks

-- First Episode Featuring Viral Genetics to Air on NBC at Noon on July 8, 2009
--
PORT JEFFERSON, N.Y.--(Business Wire)--
Wide World of Stocks, a new 30-minute pre-recorded television and website
program that features microcap companies, has secured agreements with WNBC
Channel 4 in New York and ION Television Network. As a result, the program is
expected to reach more than 100 million households nationwide. The program`s
producers aspire to scour the globe in search of microcap equities with the
potential to become the next big market mover. The show will debut Wednesday,
July 8, at noon, on NBC directly after Martha Stewart Living. The first episode
will feature Viral Genetics` (OTCPK: VRAL.PK) CEO, Mr. Haig Keledjian. Viral
Genetics is developing drug therapies for HIV/AIDS, Lyme Disease, and other
autoimmune diseases.

Additional WNBC broadcasts are scheduled for noon on Sunday, July 12th and
Sunday, July 19th, just after The Wall Street Journal Report. The current
broadcast schedule is still evolving as producers for Wide World of Stocks make
additional media buys. As agreements are developed with more networks, the
schedule will be updated and posted online at www.wideworldofstocks.com, where
episodes of the program will be available for viewing after the fist WNBC
broadcast.

Viral Genetics was chosen for the first episode of Wide World of Stocks. The
company`s drug compound called VGV-1, has already undergone five clinical trials
overseas, where it was found to reduce the viral load and symptoms of HIV/AIDS.
Due to its novel mechanism, low toxicity profile, simple dosing regimen, and
short course of treatment, researches at the company believe its therapy called
"thymus nuclear protein," (TNP) is extremely promising for other applications as
well. Details about regarding the status of Viral Genetics` drug compound and
TNP therapy are available at www.viralgenetics.com.

Wide World of Stocks will be hosted by Damon Roberts with co-hosts Roland Rick
Perry and Thomas McCarthy, "The Dean" of CollegeStock.com. Each of the hosts
manages their own websites that combined reach more than 550,000 subscribers.

About Viral Genetics, Inc.:

Viral Genetics, Inc. is engaged in the discovery and development of immune-based
therapies for HIV/AIDS and other autoimmune diseases using its thymus nuclear
protein compound (TNP). Viral Genetics believes that its investigational
HIV/AIDS drug based on TNP, called VGV-1, represents a unique approach to
treating HIV/AIDS that focuses on boosting the immune system to allow the body
to fight HIV more efficiently. See: www.viralgenetics.com. None of the
information contained on this website is incorporated by reference herein.

Not a Broker/Dealer or Financial Advisor:

We are not a Registered Broker/Dealer or Financial Advisor, nor do we hold
ourselves out to be a Registered Broker/Dealer or Financial Advisor. All
materials presented in this press release, television show and on our website
are not to be regarded as investment advice and are only for informative
purposes. Readers should verify all claims and do their own due diligence before
investing in featured companies. Investing in small-cap, micro cap and penny
stock securities is speculative and carries a high degree of risk.

No Offer of Securities:

None of the information featured in this press release constitutes an offer or
solicitation to purchase or to sell any securities of Viral Genetics, Inc.

Current Ownership of Shares:

Affiliates of Wild World Of Stocks, Inc. currently own securities of Viral
Genetics, Inc. This is an inherent conflict of interest.

Compensation:

An Affiliate of Wide World Of Stocks, Inc. has agreed to provide consulting
services to Viral Genetics, Inc. in exchange for up to 19 million shares of
common stock and 12 million warrants of Viral Genetics, Inc. upon the completion
of certain milestones. This is an inherent conflict of interest. As of the date
of this press release, no shares of common stock or warrants have been issued
pursuant to this agreement.

SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS:

Information presented in this press release contains "forward looking
statements" within the meaning of Section 27A of the Securities Exchange Act of
1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that
express or involve discussions with respect to predictions, expectations,
beliefs, plans, projections, objectives, goals, assumptions or future events or
performance are not statements of historical fact may be "forward looking
statements". Forward looking statements are based on expectations, estimates,
and projections at the time the statements are made that involve a number of
risks and uncertainties which could cause actual results or events to differ
materially from those presently anticipated. Forward looking statements in this
action may be identified through use of words such as "projects", "foresee",
"expects", "will", "anticipates", "estimates", "believes", "understands", or
that by statements indicating certain actions "may", "could", or "might" occur.
Understand there is no guarantee past performance will be indicative of future
results.

None of the information contained on our website, www.wideworldofstocks.com, is
incorporated by reference herein.

Wide World of Stocks
Investor Relations, 631-331-3234
info@wideworldofstocks.com
OR
Vogel Communications for Wide World of Stocks
Liz Vogel, 631-741-7700
liz@lizvogel.com

Copyright Business Wire 2009